Tosoh Automated Glycohemoglobin Analyzer HLC-723G8 LARecalls & reported problems
Tosoh Corporation · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 04560189282926), received between Oct 16, 2024 and Sep 17, 2026 — classified as 3 malfunctions.
The most frequently reported specific device problem is “Incorrect, Inadequate or Imprecise Result or Readings” (3 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Incorrect, Inadequate or Imprecise Result or Readings3
Patient problems
- No Clinical Signs, Symptoms or Conditions3
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
MalfunctionSep 17, 2026Incorrect, Inadequate or Imprecise Result or Readings
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 50812716 ↗MalfunctionAug 27, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
A CUSTOMER REPORTED INCORRECTLY REPORTED PATIENT RESULTS FOR HBA1C ON THE HLC-723 G8 ANALYZER. THE CUSTOMER STATED THE PATIENT'S PHYSICIAN QUESTIONED THE UNEXPECTED HIGH PATIENT RESULTS. THE CUSTOMER STATED THEY REVIEWED CHROMATOGRAMS AND FOUND SEVERAL SAMPLES WITH HBE FLAGS AS WELL AS LOW RETENTION TIME. THE CUSTOMER STATED THEY ADJUSTED THE FLOW FACTOR TO RAISE THE RETENTION TIME TO AN ACCEPTABLE NUMBER, THEN RERAN ALL SAMPLES THAT ORIGINALLY PRODUCED A RESULT WITH A HBE FLAG RESULT. THE CUSTOMER CLARIFIED THAT THE LAB TECHNICIAN RUNNING SAMPLES FOR THE DAY DID NOT REALIZE THAT THE AMOUNT OF HBE FLAGS RECEIVED WAS NOT NORMAL AND FAILED TO LOOK INTO THE REASON FOR THE NUMEROUS HBE FLAGS PRIOR TO REPORTING OUT THE RESULTS. THE CUSTOMER DID NOT PROVIDE TOSOH TECHNICAL SUPPORT SPECIALIST (TSS) WITH ANY OF THE REPORTED PATIENT RESULTS, NOR WERE ANY PATIENT TREATMENT AFFECTED. THE CUSTOMER STATED THEY ONLY REPORTED THE ISSUE FOR DOCUMENTATION PURPOSES AND DID NOT REQUIRE ANY FURTHER ACTION FROM TSS. TECHNICAL SUPPORT SPECIALIST (TSS) DETERMINED THE CAUSE OF THE REPORTED EVENT WAS TRACED TO USER ERROR. THE G8 ANALYZER IS FUNCTIONING AS EXPECTED. THERE WAS NO INDICATION OF ANY PATIENT IN
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22903516 ↗MalfunctionOct 16, 2024Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
A CUSTOMER REPORTED FAILURE OF COLLEGE OF AMERICAN PATHOLOGISTS (CAP) GH-06 SURVEY ON THE G8 ANALYZER. THE SAMPLE RESULT WAS 8.3% AND THE ACCEPTABLE RANGE IS 7.2%-8.2%. THE CUSTOMER VERIFIED THAT QUALITY CONTROL (QC) PASSED AT THE TIME OF TESTING. A TECHNICAL SUPPORT SPECIALIST (TSS) INSTRUCTED THE CUSTOMER TO RUN CALIBRATORS AS SAMPLES, WHERE CALIBRATOR 1 RESULTS ARE NOT MATCHING THE BOTTLE VALUE. THE CALIBRATOR 1 BOTTLE VALUE WAS 5.9% AND THE VALUE RESULTS WERE 4.1% WITH LOW TOTAL AREA. THERE WAS NO PROBLEM WITH CALIBRATOR 2 VALUES AND QC WAS WITHIN RANGE. A FIELD SERVICE ENGINEER (FSE) WAS DISPATCHED TO FURTHER INVESTIGATE THE REPORTED EVENT. THERE WAS NO INDICATION OF ANY PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCES DUE TO THE REPORTED EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 20467498 ↗
Other Assay, Glycosylated Hemoglobin devices
- Atellica CH A1c_E 11097536Siemens Healthcare Diagnostics Inc. · ASSAY, GLYCOSYLATED HEMOGLOBIN3 recalls25 reports
- Atellica CH Fruc 11097637Siemens Healthcare Diagnostics Inc. · ASSAY, GLYCOSYLATED HEMOGLOBIN2 recalls0 reports
- Tosoh Automated Glycohemoglobin Analyzer HLC-723G8Tosoh Corporation · Assay, Glycosylated Hemoglobin71 reports
- A1CNow®+ Multi-UseTest System (20 count) 3021Polymer Technology Systems, Inc. · ASSAY, GLYCOSYLATED HEMOGLOBIN1 recall11 reports
- ADVIA® Chemistry FRUC Reagents 10361941Siemens Healthcare Diagnostics Inc. · ASSAY, GLYCOSYLATED HEMOGLOBIN1 recall0 reports
- DCA™ Systems Hemoglobin A1c Reagent Kit 10311134Siemens Healthcare Diagnostics Inc. · ASSAY, GLYCOSYLATED HEMOGLOBIN1 recall0 reports
- Tinaquant Hemoglobin A1c III 5336163190Roche Diagnostics GmbH · ASSAY, GLYCOSYLATED HEMOGLOBIN45 reports
- Tina-quant Hemoglobin A1cDx Gen.3 08445699190Roche Diagnostics GmbH · ASSAY, GLYCOSYLATED HEMOGLOBIN11 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page